Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
about
A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicityThe efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis.Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practiceComparing etoricoxib and celecoxib for preemptive analgesia for acute postoperative pain in patients undergoing arthroscopic anterior cruciate ligament reconstruction: a randomized controlled trial.Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical studyCelecoxib for osteoarthritis.Osteoarthritis subpopulations and implications for clinical trial design.Prevalence of chronic kidney disease and associated factors among the Chinese population in Taian, China.Comparison between 200 mg QD and 100 mg BID oral celecoxib in the treatment of knee or hip osteoarthritis.Does flare trial design affect the effect size of non-steroidal anti-inflammatory drugs in symptomatic osteoarthritis? A systematic review and meta-analysis.Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib.Comparison of benefit-risk preferences of patients and physicians regarding cyclooxygenase-2 inhibitors using discrete choice experimentsA double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.Risk management profile of etoricoxib: an example of personalized medicineComparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic reviewChondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study.Comparative evaluation of cardiovascular outcomes in patients with osteoarthritis and rheumatoid arthritis on recommended doses of nonsteroidal anti-inflammatory drugs.Epidemiology research in rheumatology-progress and pitfalls.Efficacy and Safety of Celecoxib Therapy in Osteoarthritis: A Meta-Analysis of Randomized Controlled TrialsImpact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?Efficacy and safety of etoricoxib in the treatment of osteoarthritis.Comparison of effect sizes between enriched and nonenriched trials of analgesics for chronic musculoskeletal pain: a systematic review.Relative efficacy and tolerability of etoricoxib, celecoxib, and naproxen in the treatment of osteoarthritis : A Bayesian network meta-analysis of randomized controlled trials based on patient withdrawal.Sivelestat sodium hydrate improves post-traumatic knee osteoarthritis through nuclear factor-κB in a rat model.Efficacy of etoricoxib, celecoxib, lumiracoxib, non-selective NSAIDs, and acetaminophen in osteoarthritis: a mixed treatment comparisonEtoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly.Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis.Status of etoricoxib in the treatment of rheumatic diseases. Expert panel opinion.Lack of effect of antacids on single-dose pharmacokinetics of etoricoxib
P2860
Q24615651-BEB85044-623E-4165-9926-F374586EA2A6Q33556721-91FA951C-378A-43A6-B10E-5A275425BDA9Q33566361-D1706DC9-7059-4D29-8B5E-EC2F0A695590Q33727245-DABE996D-9D1F-4222-808A-70549D4486D9Q34280379-0EC684E1-BBD9-403A-B17D-289EF469E40BQ34557021-689C2085-3EB7-402D-8AD6-1FCB394C82D7Q35092973-D1A7668E-54AA-4D77-9766-26C8DFBBDFACQ35246548-E9B0664D-6356-4918-B98E-F4C421E90A56Q35642358-F3B1012D-B391-4C64-B51A-34518716E2A3Q35925230-34B00C18-03D8-47F0-95BC-47D2631F87DDQ36233306-AA5B0869-3DE3-4971-BC71-F85C5D71D9A5Q36475626-70812342-6FA1-47DC-9B97-EE9B82475F87Q36861909-A0565640-F290-4B9E-82D6-0498686741A0Q36955387-E556C74F-B956-422C-AD06-9BB606E0E93DQ37052864-AE6E902D-957B-42AE-80E0-017A832DA518Q37200568-698D08A4-1A36-4EC1-B032-FAE3114B5F7AQ37391095-A579E711-1B21-47A0-9DF2-704628310675Q38262502-39968FD3-2818-41C7-8A0C-347F47A01B38Q38543453-4D369D7B-A5E6-480C-A4E9-8FF7D3082338Q38838396-C1C4FB54-8621-4646-BF6D-F2937B29401BQ38962092-5AAEA04E-7556-408E-89D0-9EC7C097DE20Q39320502-8456A7A5-24AF-427F-9437-9175898D5DA4Q39388226-A7928DD5-7293-427C-A6F4-2BDBAFAB9729Q40976343-14577E6D-B7FB-4891-A92C-3670F3AB0D76Q41116598-B87C72DC-AFE9-4002-AE56-D7BD78241465Q41963113-922FE46B-0348-449E-88CB-D8CC85A22C7CQ47756560-1C821940-41E7-4233-9B14-322C9877F726Q48269682-F3673DEF-DDE6-4D67-9B03-A7B5123ACE50Q53602109-1D4EF7BE-BE6A-4F0B-9288-C9DAAC94CD7BQ57221140-291E233A-FD40-4308-B7F9-29C7B963FD01
P2860
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Efficacy and safety of etorico ...... lled, non-inferiority studies.
@ast
Efficacy and safety of etorico ...... lled, non-inferiority studies.
@en
Efficacy and safety of etorico ...... lled, non-inferiority studies.
@nl
type
label
Efficacy and safety of etorico ...... lled, non-inferiority studies.
@ast
Efficacy and safety of etorico ...... lled, non-inferiority studies.
@en
Efficacy and safety of etorico ...... lled, non-inferiority studies.
@nl
prefLabel
Efficacy and safety of etorico ...... lled, non-inferiority studies.
@ast
Efficacy and safety of etorico ...... lled, non-inferiority studies.
@en
Efficacy and safety of etorico ...... lled, non-inferiority studies.
@nl
P2093
P356
P1433
P1476
Efficacy and safety of etorico ...... lled, non-inferiority studies.
@en
P2093
A M Tershakovec
B J Fitzgerald
C O Bingham
S S Smugar
P304
P356
10.1093/RHEUMATOLOGY/KEL296
P577
2006-08-27T00:00:00Z